News and Events
Stay up to date with news and events
Stopping C-A-G Repeat Expansion In Its Tracks
A new study led by researchers at University College London explored a promising new way to potentially slow down Huntington disease (HD) by reducing the…
Do Antidepressants Affect Cognitive Decline? There’s More To The Story For Huntington’s Disease
Two recent studies offer fresh insights into how antidepressants, often prescribed to help manage mood and anxiety, are prescribed in Huntington’s disease (HD) and might…
Ten Golden Rules for Navigating Huntington’s Disease Research News
Real progress is being made on the road to Huntington’s disease (HD) treatments, but in today’s fast-moving digital world, it can be harder than ever…
Roche provides an update on tominersen: What’s next for this huntingtin-lowering drug?
This week, we heard an update from Roche about their huntingtin-lowering therapy, tominersen, currently being tested in the GENERATION HD2 trial. An independent data monitoring…
Knockouts for the win: how expanding CAGs drive disease
Huntington’s disease (HD) is caused by extra repeats of the DNA letters CAG within the genetic code of the huntingtin gene. We used to think…